Market Overview - U.S. equity markets have been negatively impacted by the ongoing war between Iran and Israel, leading to increased crude oil and natural gas prices due to disruptions in the Strait of Hormuz, which is crucial for global oil trade, accounting for about 20% of it [1] - The technology sector has faced challenges due to high valuations of AI stocks and uncertainty regarding the sustainability of large-scale AI investments, compounded by a crisis in the cryptocurrency market, particularly Bitcoin [2] Investment Opportunities - Despite market turbulence, investment in stocks remains advisable, with broker-favored stocks such as Cable One (CABO), Cooper-Standard (CPS), Phillips 66 (PSX), AMN Healthcare Services (AMN), and ArcBest Corporation (ARCB) being highlighted as potential opportunities [3] Stock Screening Methodology - A screening process has been established to identify stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks, incorporating the price/sales ratio as a complementary valuation metric [4] - The screening criteria include: - Top 75 companies with net upgrades in ratings over the last four weeks [5] - Top 10 stocks with significant earnings estimate revisions for the upcoming quarter [5] - Companies in the bottom 10% of price-to-sales ratio [5] - Stocks priced above $5 and with an average daily volume exceeding 100,000 shares [6] Company Highlights - **Cable One (CABO)**: Expected to achieve significant growth in 2026 through the acquisition of Mega Broadband Investments, adding approximately $310 million in annual revenues and expanding its rural broadband presence [6][7] - **Cooper-Standard (CPS)**: Anticipated earnings growth of 289% this year, driven by demand for electric vehicles and effective cost management strategies [7][10] - **Phillips 66 (PSX)**: Focused on streamlining operations and reallocating capital to enhance returns and reduce debt, with a strong performance across refining, chemicals, and midstream sectors [10][11] - **AMN Healthcare Services (AMN)**: Evolving into a total talent solutions partner, benefiting from changes in healthcare demand, particularly in acute care settings [12][13] - **ArcBest (ARCB)**: Projected earnings per share growth of 28.9% year-over-year for 2026, supported by cost control and productivity improvements [14]

Core Viewpoint - AMN Healthcare Services Inc (AMN) is showing potential for bullish movement due to a recent technical indicator known as a "golden cross," which suggests a possible breakout for investors [1]. Technical Analysis - AMN's 50-day simple moving average has recently crossed above its 200-day moving average, indicating a bullish signal [1]. - A golden cross typically follows a downtrend, where the shorter moving average crosses above the longer one, leading to a positive trend reversal [2]. Performance Metrics - AMN's stock has increased by 19.2% over the last four weeks, suggesting strong upward momentum [3]. - The company currently holds a 3 (Hold) rating on the Zacks Rank, indicating a neutral outlook [3]. Earnings Expectations - There have been three upward revisions in earnings expectations for the current quarter, with no downward changes in the past 60 days, which supports the bullish sentiment [3]. - The Zacks Consensus Estimate for AMN has also increased, further reinforcing the positive outlook for the company [4].

Company Overview - AMN Healthcare Services, Inc. is a travel healthcare staffing company based in San Diego, CA, evolving beyond traditional staffing to become a strategic total talent solutions partner for clients [11] - The company offers a diverse range of healthcare workforce solutions, including MSP, VMS, medical language interpretation services, predictive labor analytics, workforce optimization technology, consulting, clinical labor scheduling, recruitment process outsourcing (RPO), revenue cycle solutions, credentialing software services, and virtual care management services [11] Investment Ratings - AMN is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating strong overall performance [12] - The company has a Value Style Score of A, supported by attractive valuation metrics such as a forward P/E ratio of 13.93, making it appealing to value investors [12] Earnings Estimates - In the last 60 days, three analysts have revised their earnings estimates upwards for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.70 to $1.46 per share [12] - AMN has demonstrated an average earnings surprise of +79.6%, indicating strong performance relative to expectations [12] Investment Consideration - With a solid Zacks Rank and top-tier Value and VGM Style Scores, AMN Healthcare Services should be considered for investors' short lists [13]

分组1 - Long Cast Advisers reported a cumulative net return increase of 1% in Q4 2025, with a flat cumulative portfolio return for the year, and a total cumulative return of 271% net of fees since inception in November 2015 [1] - The firm managed 28 SMA accounts with an AUM of $12 million by year-end 2025, focusing on small companies and demonstrating varied returns relative to the broader market over a 10-year performance history [1] - The portfolio's top five holdings provide insights into key selections for 2025, indicating a strategic focus on specific stocks [1] 分组2 - Cross Country Healthcare, Inc. (NASDAQ:CCRN) was highlighted as a significant stock, with a market capitalization of $318.34 million and a one-month return of 23.02%, despite a 52-week loss of 37.94% [2] - The company specializes in talent management services for healthcare clients, particularly in nurse and allied staffing, and physician staffing [2] - Long Cast Advisers made significant purchases of Cross Country Healthcare, Inc. at an average price of $8.24 per share, revisiting the stock after previously selling it during negative COVID comparisons [3] - Cross Country Healthcare, Inc. has $99 million in net cash and no debt, with a pro forma enterprise value of $140 million after receiving a $20 million termination payment from a failed acquisition [3]

Core Insights - Cross Country Healthcare (CCRN) reported a revenue of $236.76 million for the quarter ended December 2025, reflecting a year-over-year decline of 23.6% [1] - The earnings per share (EPS) for the same period was -$0.06, compared to $0.04 a year ago, indicating a significant drop [1] - The reported revenue was 6.14% lower than the Zacks Consensus Estimate of $252.25 million, and the EPS surprise was -300% against the consensus estimate of $0.03 [1] Financial Performance Metrics - Cross Country's shares returned -0.2% over the past month, while the Zacks S&P 500 composite experienced a -1.3% change, suggesting relative stability [3] - The company holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3] Staffing and Revenue Data - Nurse and allied staffing reported 6,318 full-time equivalents (FTEs), which was below the estimated average of 6,535 by two analysts [4] - Physician staffing revenue per day filled was $2,286.00, exceeding the estimated average of $2,053.50 by two analysts [4] - Days filled in hours (HRS) for physician staffing were 18,599, surpassing the average estimate of 16,832 [4] - Revenue from physician staffing was $42.52 million, which was lower than the estimated average of $49.66 million by three analysts, representing a year-over-year decline of 19.8% [4] - Revenue from nurse and allied staffing was $194.24 million, below the estimated average of $203.75 million by three analysts, reflecting a year-over-year change of -24.4% [4]

Core Viewpoint - Cross Country Healthcare is experiencing a stabilization in the healthcare staffing market, particularly in travel staffing, with expectations for growth in 2026 despite a challenging 2025 due to a terminated merger [3][2]. Financial Performance - Q4 revenue was $237 million, down 24% year-over-year, and full-year revenue was $1.05 billion, down 22% [5][7]. - Adjusted EBITDA for Q4 was $4 million, with a full-year adjusted EBITDA of $27 million, reflecting margins of 1.7% and 2.5% respectively [9][5]. - The company recorded a $78 million non-cash impairment charge related to the terminated merger, impacting below-EBITDA results [10][5]. Market Outlook - The company expects travel staffing to be flat to slightly up sequentially, with Travelers On Assignment projected to grow each month into Q2 [2][6]. - Management anticipates a revenue run rate exceeding $1 billion by the end of 2026, with an adjusted EBITDA margin of 4% to 5% [4][22]. Operational Strategy - The company is focusing on technology and operational efficiency, with plans to expand its workforce intelligence platform, Intellify, into new staffing markets [16][17]. - Cross Country Healthcare aims to enhance recruiter productivity and back-office efficiency through automation and AI initiatives [17][18]. Segment Performance - Travel staffing revenue declined 30% year-over-year, while home-based staffing grew 34% year-over-year, indicating a shift in demand [11][14]. - Education staffing revenue increased 48% sequentially, with expectations for growth in 2026 [13][12]. Balance Sheet and Shareholder Actions - The company ended the quarter with $109 million in cash and no debt, having repurchased over 1.3 million shares recently [4][19]. - Management believes the stock does not reflect its underlying value and anticipates further share repurchases [20].

Financial Data and Key Metrics Changes - Consolidated revenue for Q4 2025 was $237 million, down 5% sequentially and 24% year-over-year. Full-year revenue was $1.05 billion, down 22% from the prior year [15][16] - Gross profit for the quarter was $48 million, representing a gross margin of 20.3%, down 10 basis points sequentially but up 30 basis points year-over-year [16] - Adjusted EBITDA was $40 million for the quarter, with a margin of 1.7%, and $27 million for the full year, with a margin of 2.5% [18] Business Line Data and Key Metrics Changes - Nurse and Allied reported revenue of $194 million for the quarter, down 4% sequentially and 24% year-over-year. Travel Nurse revenue was down 9% sequentially and 30% year-over-year [21] - Home-based staffing revenue was $34 million in Q4, up 34% year-over-year, with continued growth anticipated [23] - Education staffing revenue was $18 million, up 48% sequentially but down 7% year-over-year [22] Market Data and Key Metrics Changes - The healthcare staffing market is stabilizing, with demand and bill rates showing signs of improvement. The number of Travelers On Assignment is expected to grow each month into Q2 2026 [7][21] - The company anticipates a flat to slightly up sequential growth in travel staffing for the first time in over three years [7] Company Strategy and Development Direction - The company aims to expand market share within large health systems, improve operational efficiency, and leverage technology as a differentiator [6][10] - A focus on operational rigor, technology-powered workforce solutions, and disciplined capital allocation is central to the company's strategy for long-term shareholder value [5][6] - The company plans to expand its proprietary technology portfolio, including Intellify, into adjacent sectors such as home-based and education staffing [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to revenue and earnings growth by the end of 2026, supported by a strong balance sheet and cash position [6][12] - The company is optimistic about the stabilization of the market and expects to see sequential growth across all lines of business throughout 2026 [30][64] Other Important Information - The company ended Q4 with $109 million in cash and no outstanding debt, positioning it well for strategic investments and capital allocation [24] - The company has repurchased over 800,000 shares in December and continued to buy back shares in Q1 2026, indicating confidence in its stock value [24] Q&A Session Summary Question: What is the confidence in achieving the revenue run rate above $1 billion and EBITDA margins of 4%-5%? - Management expressed high confidence due to a large sales pipeline, market-leading technology, and a strong balance sheet [30][32] Question: What are the opportunities for M&A in the current market? - The company is focused on strategic acquisitions in home-based staffing and is looking for accretive tuck-in acquisitions while being patient in capital allocation [36][37] Question: How is the technology platform Intellify being expanded into other markets? - The company plans to expand Intellify into home care and education staffing markets in 2026, with a strategy to provide solutions across the continuum of care [41][42] Question: What impact has labor disruption had on the business? - The company has participated in labor disruption events but noted that it is not a core business and the impact has been minimal [45][46] Question: What is the outlook for sequential revenue growth throughout 2026? - Management expects sequential growth across all quarters, with a target for year-over-year growth in the back half of 2026 [63][64]

Financial Data and Key Metrics Changes - Consolidated revenue for Q4 2025 was $237 million, down 5% sequentially and 24% year-over-year. Full-year revenue was $1.05 billion, down 22% from the prior year [15][16] - Gross profit for the quarter was $48 million, representing a gross margin of 20.3%, down 10 basis points sequentially but up 30 basis points year-over-year [16] - Adjusted EBITDA was $40 million for the quarter, with a margin of 1.7%, and $27 million for the full year, with a margin of 2.5% [18] Business Line Data and Key Metrics Changes - Nurse and Allied reported revenue of $194 million for the quarter, down 4% sequentially and 24% year-over-year. Travel Nurse revenue was down 9% sequentially and 30% year-over-year [21] - Home-based staffing revenue was $34 million in Q4, up 34% year-over-year, with continued growth anticipated due to an aging population [23] - Education staffing revenue was $18 million, up 48% sequentially but down 7% year-over-year, with expectations for growth in 2026 [22] Market Data and Key Metrics Changes - The healthcare staffing market is stabilizing, with demand and bill rates showing signs of improvement. The number of Travelers On Assignment is expected to grow each month into Q2 2026 [7][21] - The company anticipates a flat to slightly up sequential growth in travel staffing for the first time in over three years [7] Company Strategy and Development Direction - The company aims to restore momentum and sharpen execution, focusing on expanding market share within large health systems and leveraging technology as a differentiator [5][6] - A disciplined capital allocation strategy is in place, with plans for strategic investments and share repurchases to enhance shareholder value [12][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to revenue and earnings growth by the end of 2026, supported by a strong balance sheet and cash position [6][12] - The company is optimistic about the stabilization of the market and expects to see sequential growth across all business lines throughout 2026 [50][66] Other Important Information - The company ended Q4 2025 with $109 million in cash and no outstanding debt, positioning it well for strategic investments [24] - The company has made significant investments in revenue producers, which are already yielding positive results [11] Q&A Session Summary Question: What is the confidence level in achieving the revenue run rate above $1 billion and EBITDA margins of 4%-5%? - Management expressed high confidence due to a strong sales pipeline, market-leading technology, and a solid balance sheet [30] Question: What needs to happen to achieve the higher margin levels by the end of the year? - Management indicated that operating leverage and a better mix of higher-margin businesses will contribute to margin improvement [33] Question: What opportunities do you see for M&A in the current market? - The company is focused on strategic acquisitions in high-growth areas like home-based staffing and is being patient in its capital allocation strategy [36] Question: Can you provide details on the expansion of the Intellify platform into other markets? - The company plans to expand Intellify into home-based and education staffing markets in 2026, with a focus on providing comprehensive solutions across all divisions [41][42] Question: How is the Center of Excellence in India contributing to cost savings? - The Center has reduced headcount and moved many business processes offshore, resulting in significant operational leverage and efficiency improvements [68]

Financial Data and Key Metrics Changes - Consolidated revenue for Q4 2025 was $237 million, down 5% sequentially and 24% year-over-year. Full-year revenue was $1.05 billion, down 22% from the prior year [13][14] - Gross profit for the quarter was $48 million, representing a gross margin of 20.3%, down 10 basis points sequentially but up 30 basis points year-over-year [15] - Adjusted EBITDA was $40 million for the quarter, with a margin of 1.7%, and $27 million for the full year, with a margin of 2.5% [17] Business Line Data and Key Metrics Changes - Nurse and Allied reported revenue of $194 million for the quarter, down 4% sequentially and 24% year-over-year. Travel Nurse revenue was down 9% sequentially and 30% year-over-year [20] - Home-based staffing revenue was $34 million in Q4, up 34% year-over-year, with continued growth anticipated [23] - Education staffing revenue was $18 million, up 48% sequentially but down 7% year-over-year, with expectations for growth in 2026 [21][22] Market Data and Key Metrics Changes - The healthcare staffing market is stabilizing, with demand and bill rates showing signs of improvement. The number of Travelers On Assignment is expected to grow each month into Q2 2026 [6][20] - The company anticipates a flat to slightly up sequential growth in travel staffing for the first time in over three years [6] Company Strategy and Development Direction - The company aims to expand market share within large health systems, improve operational efficiency, and leverage technology as a differentiator [5] - A focus on operational rigor, technology-powered workforce solutions, and disciplined capital allocation is central to the company's strategy for long-term shareholder value [4] - The company plans to expand its proprietary technology portfolio, particularly the Intellify platform, into adjacent markets such as home-based and education staffing [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to revenue and earnings growth by the end of 2026, supported by a strong balance sheet and cash position [5][11] - The company is optimistic about the stabilization of the market and the potential for growth in various business lines, particularly travel and home-based staffing [6][32] Other Important Information - The company ended Q4 with $109 million in cash and no outstanding debt, positioning it well for strategic investments and share repurchases [24] - The company has made significant investments in revenue producers, which are expected to drive organic growth throughout 2026 [10][17] Q&A Session Summary Question: What is the confidence in achieving the revenue run rate above $1 billion and 4%-5% EBITDA margins by the end of 2026? - Management expressed high confidence due to a strong sales pipeline, market-leading technology, and a solid balance sheet [31][32] Question: What are the opportunities for M&A in the current market? - The company is focused on disciplined capital allocation and is exploring accretive tuck-in acquisitions, particularly in home-based staffing [39] Question: How is the technology platform Intellify being expanded into other markets? - The company plans to expand Intellify into home care and education staffing markets in 2026, with a strategy to provide solutions across the continuum of care [43][44] Question: What impact has labor disruption had on the business? - The company has participated in labor disruption events but noted that it is not a core business and the impact has been minimal [46][48] Question: What is the outlook for sequential revenue growth throughout 2026? - Management expects sequential growth across all quarters, with a target for year-over-year growth in the back half of the year [65][66]

Company Insights - Arrow Electronics is one of the world's largest distributors of electronic components and enterprise computing products, with a projected 3-5 year EPS growth rate of 15.2% and a Zacks Rank 1 (Strong Buy) [6][8] - Arrow's recent partnerships, including collaboration with .lumen for AI-powered assistive technology, highlight its innovation leadership and are expected to bolster future growth [7] - Gold.com operates as a fully integrated alternative assets platform, with a stock price that has surged 83% over the past three months and an expected earnings growth rate of 63.1% for the current year, also holding a Zacks Rank 1 [9][10] - Cross Country Healthcare provides talent management and consultative services for healthcare clients, benefiting from strong relationships and momentum in home care and physician staffing, currently holding a Zacks Rank 3 (Hold) [11][12] - AMN Healthcare Services has evolved into a strategic total talent solutions partner, with a unique MSP that streamlines workforce planning and improves patient care, also holding a Zacks Rank 3 [13][14] - PENN Entertainment is recognized for consistent strategy execution and strong brand recognition, with earnings surpassing the Zacks Consensus Estimate in three of the last four quarters, currently holding a Zacks Rank 3 [15] Market Trends - The technology sector has experienced a sharp downturn due to investor concerns regarding the sustainability of the AI trade and elevated valuations of AI stocks, alongside sell-offs in cryptocurrencies like Bitcoin [2] - Despite market volatility, investors are encouraged to consider broker-favored stocks, indicating potential investment opportunities in the current environment [3]